{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,29]],"date-time":"2022-03-29T04:32:31Z","timestamp":1648528351249},"reference-count":34,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2009,10,1]],"date-time":"2009-10-01T00:00:00Z","timestamp":1254355200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pathology - Research and Practice"],"published-print":{"date-parts":[[2009,10]]},"DOI":"10.1016\/j.prp.2009.03.007","type":"journal-article","created":{"date-parts":[[2009,5,15]],"date-time":"2009-05-15T17:19:23Z","timestamp":1242407963000},"page":"682-689","source":"Crossref","is-referenced-by-count":5,"title":["E-cadherin expression in upper urothelial carcinoma in Balkan Endemic Nephropathy and non-endemic regions"],"prefix":"10.1016","volume":"205","author":[{"given":"Ljubinka Jankovic","family":"Velickovic","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takanori","family":"Hattori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Milan","family":"Visnjic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irena","family":"Dimov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariola","family":"Stojanovic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vladisav","family":"Stefanovic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.prp.2009.03.007_bib1","first-page":"5","article-title":"Urinary tract tumors in Kolubara region","volume":"11","author":"Bukvic","year":"2004","journal-title":"Facta Universitatis"},{"key":"10.1016\/j.prp.2009.03.007_bib2","first-page":"925","article-title":"E-cadherin mRNA expression analysis in evaluating the natural history of urothelial bladder cell carcinoma: results from a long-term follow-up study","volume":"17","author":"Cai","year":"2007","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.prp.2009.03.007_bib3","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1136\/mp.55.2.80","article-title":"Molecular histology in the study of solid tumours","volume":"55","author":"Campbell","year":"2002","journal-title":"Mol. Pathol."},{"key":"10.1016\/j.prp.2009.03.007_bib4","first-page":"180","article-title":"Correlation of E-cadherin expression with clinicopathological data in patients suffering from transitional cell carcinoma of the bladder","volume":"25","author":"Charalabopoulos","year":"2003","journal-title":"Exp. Oncol."},{"key":"10.1016\/j.prp.2009.03.007_bib5","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1111\/j.1365-2559.2007.02949.x","article-title":"Membrane loss and aberrant nuclear localization of E-cadherin are consistent features of solid pseudopapillary tumor of the pancreas. An immunohistochemical study using two antibodies recognizing different domains of the E-cadherin molecule","volume":"52","author":"Chetty","year":"2008","journal-title":"Histopathology"},{"key":"10.1016\/j.prp.2009.03.007_bib6","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1309\/DKCL-N4K2-RK0V-87YG","article-title":"Expression of E-cadherin and alpha-, beta-, gamma-catenins in patients with bladder cancer: identification of gamma-catenin as a new prognostic marker of neoplastic progression in T1 superficial urothelial tumors","volume":"125","author":"Clairotte","year":"2006","journal-title":"Am. J. Clin. Pathol."},{"key":"10.1016\/j.prp.2009.03.007_bib7","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1097\/PAS.0b013e318158d6c5","article-title":"Aberrant expression of E-cadherin in lobular carcinomas of the breast","volume":"32","author":"Da Silva","year":"2008","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.prp.2009.03.007_bib8","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1111\/j.1464-410X.2008.07659.x","article-title":"Molecular and histological markers in urothelial carcinomas of the upper urinary tract","volume":"102","author":"Eltz","year":"2008","journal-title":"Br. J. Urol. Int."},{"key":"10.1016\/j.prp.2009.03.007_bib9","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1016\/j.eururo.2005.07.005","article-title":"Tissue microarray analysis of the prognostic value of E-cadherin, Ki-67, p53, p27, survivin and MSH2 expression in upper urinary tract transitional cell carcinoma","volume":"48","author":"Fromont","year":"2005","journal-title":"Eur. Urol."},{"key":"10.1016\/j.prp.2009.03.007_bib10","doi-asserted-by":"crossref","first-page":"S12","DOI":"10.1007\/BF00182058","article-title":"The significance of E-cadherin in transitional-cell carcinoma of the human urinary bladder","volume":"14","author":"Fujisawa","year":"1996","journal-title":"World J. Urol."},{"key":"10.1016\/j.prp.2009.03.007_bib11","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/modpathol.3800268","article-title":"Impact of the 1998 World Health Organization\/International Society of Urological Pathology classification system for urothelial neoplasms of the kidney","volume":"18","author":"Genega","year":"2005","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.prp.2009.03.007_bib12","first-page":"S36","article-title":"Urothelial neoplasms of the kidney and ureter","volume":"117","author":"Genega","year":"2002","journal-title":"Am. J. Clin. Pathol."},{"key":"10.1016\/j.prp.2009.03.007_bib13","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1097\/01.ju.0000046242.55722.1c","article-title":"Hypermethylation of an E-cadherin (CDH-1) promoter region in high grade transitional cell carcinoma of the bladder comprising carcinoma in situ","volume":"169","author":"Horikawa","year":"2003","journal-title":"J. Urol."},{"key":"10.1016\/j.prp.2009.03.007_bib14","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1097\/00000478-200007000-00009","article-title":"The invasive component of urothelial carcinoma of the bladder and its relationship with progression \u2013 free survival","volume":"24","author":"Jimenez","year":"2000","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.prp.2009.03.007_bib15","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1177\/107327480000700401","article-title":"Molecular mechanisms and pathways in bladder cancer development and progression","volume":"7","author":"Jung","year":"2000","journal-title":"Cancer Control"},{"key":"10.1016\/j.prp.2009.03.007_bib16","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/j.eururo.2005.12.023","article-title":"The prognostic value of E-cadherin, alpha-, beta-, and gamma-catenin in urothelial cancer of the upper urinary tract","volume":"49","author":"Kashibuchi","year":"2005","journal-title":"Eur. Urol."},{"key":"10.1016\/j.prp.2009.03.007_bib17","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/BF02893426","article-title":"Reduced E-cadherin and \u03b1-catenin expressions have no prognostic role in bladder carcinoma","volume":"12","author":"Koksal","year":"2006","journal-title":"Pathol. Oncol. Res."},{"key":"10.1016\/j.prp.2009.03.007_bib18","doi-asserted-by":"crossref","first-page":"2780","DOI":"10.1158\/1078-0432.CCR-05-2387","article-title":"N-cadherin as a novel prognostic marker of progression in superficial urothelial tumors","volume":"12","author":"Lascombe","year":"2006","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.prp.2009.03.007_bib19","doi-asserted-by":"crossref","first-page":"713","DOI":"10.2214\/ajr.155.4.2119098","article-title":"Transitional cell carcinoma of the pelvicalices and ureter","volume":"155","author":"Leder","year":"1990","journal-title":"Am. J. Roentgenol."},{"key":"10.1016\/j.prp.2009.03.007_bib20","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/BF01209598","article-title":"Reduced expression of E-cadherin is related to invasive disease and frequent recurrence in bladder cancer","volume":"121","author":"Lipponen","year":"1995","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"10.1016\/j.prp.2009.03.007_bib21","series-title":"World Health Organization Classification of Tumours. Pathology and Genetics. Tumours of the Urinary System and Male Genital Organs","first-page":"93","article-title":"Tumors of the urinary system. Infiltrating urothelial carcinoma","author":"Lopez-Beltran","year":"2004"},{"key":"10.1016\/j.prp.2009.03.007_bib22","first-page":"1339","volume":"60","author":"Mihatsch","year":"1982","journal-title":"Phenacetin abuse and malignant tumors. An autopsy study covering 25 years (1953\u20131977). Klin. Wochenschr."},{"key":"10.1016\/j.prp.2009.03.007_bib23","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1002\/(SICI)1097-0215(19970822)74:4<446::AID-IJC15>3.0.CO;2-7","article-title":"E-cadherin expression in upper-urinary-tract carcinoma","volume":"74","author":"Nakanishi","year":"1997","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.prp.2009.03.007_bib24","first-page":"425","article-title":"E-cadherin expression during urothelial carcinogenesis induced by N-butyl-N-(4-hydroxybutyl) nitrosamine in rats","volume":"25","author":"Oliveira","year":"2006","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.prp.2009.03.007_bib25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1475-2867-3-1","article-title":"Tumor suppressor gene E-cadherin and its role in normal and malignant cells","volume":"3","author":"Pecina-Straus","year":"2003","journal-title":"Cancer Cell Intern."},{"key":"10.1016\/j.prp.2009.03.007_bib26","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1054\/bjoc.2000.1233","article-title":"Low E-cadherin expression in bladder cancer at the transcriptional and protein level provides prognostic information","volume":"83","author":"Popov","year":"2000","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.prp.2009.03.007_bib27","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1053\/hupa.2001.21140","article-title":"Expression of classic cadherins type I in urothelial neoplastic progression","volume":"32","author":"Rieger-Christ","year":"2001","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.prp.2009.03.007_bib28","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1097\/00125480-200101000-00006","article-title":"Biomarkers for the detection of bladder cancer","volume":"8","author":"Ross","year":"2001","journal-title":"Adv. Anat. Pathol."},{"key":"10.1016\/j.prp.2009.03.007_bib29","doi-asserted-by":"crossref","first-page":"355","DOI":"10.4321\/S0210-48062007000400007","article-title":"E-cadherin and catenins expression in urothelial carcinoma","volume":"31","author":"San Miguel Fraile","year":"2007","journal-title":"Actas Urol. Esp."},{"key":"10.1016\/j.prp.2009.03.007_bib30","first-page":"296","article-title":"Nuclear expression of E-cadherin in solid pseudopapillary tumors of the pancreas","volume":"8","author":"Serra","year":"2007","journal-title":"JOP"},{"key":"10.1016\/j.prp.2009.03.007_bib31","series-title":"TNM Classification of Malignant Tumors","year":"2002"},{"key":"10.1016\/j.prp.2009.03.007_bib32","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/ncpuro1019","article-title":"Balkan endemic nephropathy and associated urothelial cancer","volume":"5","author":"Stefanovic","year":"2008","journal-title":"Nat. Clin. Pract. Urol."},{"key":"10.1016\/j.prp.2009.03.007_bib33","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.anndiagpath.2003.11.007","article-title":"E-cadherin expression in invasive urothelial carcinoma","volume":"8","author":"Sun","year":"2004","journal-title":"Ann. Diagn. Pathol."},{"key":"10.1016\/j.prp.2009.03.007_bib34","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/BF02893447","article-title":"E-cadherin expression in transitional cell carcinomas","volume":"12","author":"Szekely","year":"2006","journal-title":"Pathol. Oncol. Res."}],"container-title":["Pathology - Research and Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033809001095?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033809001095?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,20]],"date-time":"2019-05-20T04:49:09Z","timestamp":1558327749000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0344033809001095"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,10]]},"references-count":34,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2009,10]]}},"alternative-id":["S0344033809001095"],"URL":"https:\/\/doi.org\/10.1016\/j.prp.2009.03.007","relation":{},"ISSN":["0344-0338"],"issn-type":[{"value":"0344-0338","type":"print"}],"subject":[],"published":{"date-parts":[[2009,10]]}}}